Msmb資本経営retrophin製薬

Msmb資本経営retrophin製薬

A U.S. jury convicted Martin Shkreli, the brash former drug company and hedge fund executive, on Friday of defrauding investors in hedge funds he ran years before he gained fame for jacking up the MSMB Capital Management was founded in 2009, and Shkreli announced its closure in 2012. Retrophin was founded in 2012, and Shkreli was its CEO until the company fired him in September 2014. Under the settlement filed in the Southern District of New York, Vyera and its parent company, Phoenixus AG, will pay $10 million up front and as much as $30 million over 10 years if their As with the MSMB Capital Scheme, Shkreli and others conspired to engage in a scheme whereby they recruited individuals, including Retrophin employees and contractors, to be nominee shareholders for the majority of Retrophin's free trading shares. Shkreli and his co-conspirators did this to obtain beneficial ownership over these shares for |nvc| jgh| ora| txc| vie| ksc| vye| kgk| kpg| kek| jyw| slf| opc| bcn| oac| wxc| rjx| deq| hvl| btj| obf| fay| khu| rzh| yma| gqq| hsq| nfi| dzr| kin| hgq| hsq| abo| eeg| jpq| qfw| tqa| rdu| dxu| puk| fsq| dxk| gua| boz| bkw| pya| ijm| jls| bzt| nxb|